Neusoft Medical (Chinese:\u4e1c\u8f6f\u533b\u7597) and Cardiologists & Partners (Chinese:\u534e\u533b\u5fc3\u8bda\u533b\u751f\u96c6\u56e2) have signed a strategic agreement. Based on their high-end medical equipment and leading cardiologists’ resources, the two sides are to improve cardiovascular diagnostics levels in China by helping hospitals at all levels improve and develop their cardiovascular capabilities.<\/p>\n\n\n\n
Cardiologists & Partners is a medical group founded by 23 top cardiologists in China including Professor Huo Yong (Chinese:\u970d\u52c7) from the First Hospital of Peking University, and Professor Ge Junbo (Chinese:\u845b\u5747\u6ce2), an academician of the Chinese Academy of Science, from Zhongshan Hospital affiliated to Fudan University. The group is to help more hospitals improve cardiovascular intervention levels by establishing a sound evaluation standard system for the construction of cardiovascular disciplines and a comprehensive plan for the training of cardiovascular experts and techniques.<\/p>\n\n\n\n
\nChina is undergoing a transition from “disease-focused” to “health-focused” with emerging a lot of new medical technologies, we should continue to lead technological innovation, innovate the medical model, establish a sound medical system, and cooperate with the players in the whole industry, to achieve the scientific management of cardiovascular diseases.<\/p>\nHuo Yong, Ge Junbo, and Other Cardiologists<\/cite><\/blockquote>\n\n\n\n
Neusoft Medical is one of the leading players in high-end medical equipment in China. More than 45,000 units of its equipment have been installed in 110 countries since the launch of China’s first CT system in 1997.<\/p>","protected":false},"excerpt":{"rendered":"
the two sides are to improve cardiovascular diagnostics levels in China by helping hospitals at all levels improve and develop their cardiovascular capabilities<\/p>","protected":false},"author":2,"featured_media":16021,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"colormag_page_layout":"default_layout","footnotes":""},"categories":[5,488,680,10],"tags":[453],"class_list":["post-16019","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-asia-pacific","category-breaking-news","category-cardiovascular","category-strategic-development","tag-china"],"_links":{"self":[{"href":"https:\/\/g-medtech.com\/news\/de\/wp-json\/wp\/v2\/posts\/16019","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/g-medtech.com\/news\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/g-medtech.com\/news\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/de\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/de\/wp-json\/wp\/v2\/comments?post=16019"}],"version-history":[{"count":3,"href":"https:\/\/g-medtech.com\/news\/de\/wp-json\/wp\/v2\/posts\/16019\/revisions"}],"predecessor-version":[{"id":16024,"href":"https:\/\/g-medtech.com\/news\/de\/wp-json\/wp\/v2\/posts\/16019\/revisions\/16024"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/de\/wp-json\/wp\/v2\/media\/16021"}],"wp:attachment":[{"href":"https:\/\/g-medtech.com\/news\/de\/wp-json\/wp\/v2\/media?parent=16019"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/de\/wp-json\/wp\/v2\/categories?post=16019"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/de\/wp-json\/wp\/v2\/tags?post=16019"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}